Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing PerspectivesLuisa Carbognin, Maria Vittoria Dieci, Federica Miglietta et al.|Cancers|2019Cited by 115
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Daniele Generali, Fabiola Giudici et al.|JNCI Journal of the National Cancer Institute|2020Cited by 102
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysisFrancesco Schettini, Daniele Generali, Ottavia Bernocchi et al.|European Journal of Cancer|2021Cited by 65
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Daniele Generali, Sergio Venturini et al.|Cancer Treatment Reviews|2022Cited by 35
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Daniele Generali, Mario Giuliano et al.|Cancers|2021Cited by 19